In a melanoma model, TCR-transgenic CD4+ T cells (gDT-II) infiltrated tumors and interacted with MHC II+ antigen-presenting cells carrying tumor debris, suppressing or eradicating tumors independently of other lymphocytes. This evidence concerns the gene CD4 and neoplasm.